logo

Clearside Biomedical, Inc. (CLSD)



Trade CLSD now with
  Date
  Headline
7/29/2019 7:18:50 AM Wedbush Reiterates Clearside Biomedical, Inc. (CLSD) At Outperform With $4 Price Target
7/10/2019 6:49:54 AM Wedbush Reiterates Clearside Biomedical, Inc. (CLSD) At Outperform With $4 Price Target
7/9/2019 7:12:33 AM Clearside Biomedical Enters Worldwide Licensing Agreement With Aura Biosciences
5/9/2019 7:50:06 AM Wedbush Is Raising Clearside Biomedical, Inc. (CLSD) FY20 Rev. Estimate To 7.6 M From 7.4 M
5/9/2019 7:49:50 AM Wedbush Is Raising Clearside Biomedical, Inc. (CLSD) Q3 20 Rev. Estimate To 2.1 M From 2.0 M
5/9/2019 7:49:36 AM Wedbush Is Increasing Clearside Biomedical, Inc. (CLSD) Q2 20 Rev. Estimate To 1.6 M From 1.5 M
5/9/2019 7:49:25 AM Wedbush Is Increasing Clearside Biomedical, Inc. (CLSD) Q1 20 Rev. Estimate To 1.2 M From 1.1 M
5/9/2019 7:48:56 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) FY20 Estimate To -1.38 From -0.82
5/9/2019 7:48:38 AM Wedbush Is Cutting Clearside Biomedical, Inc. (CLSD) Q4 20 Estimate To -0.39 From -0.23
5/9/2019 7:48:26 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) Q3 20 Estimate To -0.36 From -0.21
5/9/2019 7:48:08 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) Q2 20 Estimate To -0.33 From -0.20
5/9/2019 7:47:56 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) Q1 20 Estimate To -0.31 From -0.18
5/9/2019 7:47:36 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) FY19 Estimate To -1.37 From -0.79
5/9/2019 7:46:59 AM Wedbush Is Cutting Clearside Biomedical, Inc. (CLSD) Q4 19 Estimate To -0.31 From -0.19
5/9/2019 7:46:45 AM Wedbush Is Cutting Clearside Biomedical, Inc. (CLSD) Q3 19 Estimate To -0.29 From -0.18
5/9/2019 7:46:25 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) Q2 19 Estimate To -0.33 From -0.19
5/9/2019 7:45:50 AM Wedbush Reiterates Clearside Biomedical, Inc. (CLSD) At Outperform With $4 Price Target
4/8/2019 7:07:50 AM Clearside Biomedical Appoints George Lasezkay Interim CEO
2/20/2019 7:11:37 AM Clearside Biomedical Gets Notification Of FDA Acceptance Of NDA Filing For XIPERE For Suprachoroidal Injection